PCA3 IS A TRUE ONCOMARKER OF PROSTATE CANCER: A REVIEW OF LITERATURE

PCA3 IS A TRUE ONCOMARKER OF PROSTATE CANCER: A REVIEW OF LITERATURE

Show other versions (1)

<p>Routine measurement of prostate-specific antigen (PSA) levels has resulted in the increased number of prostate biopsies. The lower age-related reference values of PSA have in its turn led to the larger number of unnecessary prostate biopsies (to the hyperdiagnosis of clinically insignifican...

Full description

Bibliographic Details
Main Authors:	A. V. Sidorenkov, D. Yu. Pushkar
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Onkourologiâ
Subjects:	prostate cancer biomarker PCA3 prostate biopsy reverse transcription real-time polymerase chain reaction
Online Access:	http://oncourology.abvpress.ru/index.php/oncur/article/view/66

Similar Items

PCA3 IS A TRUE ONCOMARKER OF PROSTATE CANCER: A REVIEW OF LITERATURE
by: A. V. Sidorenkov, et al.
Published: (2014-07-01)

Quantitation of α<sub>1A</sub> and α<sub>1D</sub>-adrenoceptor mRNA in prostate tissues from patients with symptomatic benign prostatic hyperplasia
by: B Acharya, et al.
Published: (2011-03-01)

PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?
by: Pietro Pepe, et al.
Published: (2012-08-01)

The novel prostate cancer antigen 3 (PCA3) biomarker
by: Andreas Bourdoumis, et al.
Published: (2010-12-01)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
by: Virginie Vlaeminck-Guillem, et al.
Published: (2013-08-01)

Comparative analysis of the rate of microorganism detection in the prostatic fluid and ejaculate using real-time polymerase chain reaction in patients with category IV chronic prostatitis
by: D. G. Pochernikov, et al.
Published: (2020-04-01)

Expression of KLK2 gene in prostate cancer
by: Sajad Shafai, et al.
Published: (2018-01-01)

Possibility of using PCA3 score without prostate massage in urine for diagnosing prostate cancer
by: A. A. Musaelyan, et al.
Published: (2021-02-01)

Diagnostic value of [-2]proPSA and PHI index (review of literature)
by: A. V. Sidorenkov, et al.
Published: (2014-12-01)

Strategic planning to augment the testing capacity for COVID-19 in India
by: Nivedita Gupta, et al.
Published: (2020-01-01)

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis
by: Yong Luo, et al.
Published: (2014-06-01)

Diagnostic value of [-2]proPSA and PHI index (review of literature)
by: A. V. Sidorenkov, et al.
Published: (2014-12-01)

The Role of Multiplex Polymerase Chain Reaction in Detecting Etiological Causes of Bacterial Prostatitis Associated Benign Prostatic Hyperplasia
by: Bramastha Rosadi, et al.
Published: (2015-01-01)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

Detection of Epstein–Barr virus in prostate tissue from prostatic cancer patients in Iraq
by: Anwar Abd Hashim Al-Ramahy
Published: (2021-01-01)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
by: Jochen Neuhaus, et al.
Published: (2018-09-01)

Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy
by: Sudhir Bhandari, et al.
Published: (2021-01-01)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01)

SATURATION BIOPSY OF THE PROSTATE (REVIEW)
by: A. V. Sadchenko, et al.
Published: (2014-07-01)

SATURATION BIOPSY OF THE PROSTATE (REVIEW)
by: A. V. Sadchenko, et al.
Published: (2014-07-01)

Negative Biopsies with Rising Prostate-Specific Antigen. What To Do?
by: Juan Gómez Rivas, et al.
Published: (2017-05-01)

Integrative molecular characterization of Chinese prostate cancer specimens
by: Shi-Dong Lv, et al.
Published: (2020-01-01)

BIOMARKERS FOR DIAGNOSING OF PROSTATE CANCER: THE PRESENT AND THE FUTURE
by: L. M. Rapoport, et al.
Published: (2018-05-01)

Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer
by: A. A. Musaelyan, et al.
Published: (2020-07-01)

Current laboratory diagnosis of coronavirus disease 2019
by: Jihyang Lim, et al.
Published: (2020-07-01)

Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
by: de Albuquerque Andreia, et al.
Published: (2012-11-01)

Semiquantitative analysis of intrahepatic CC-chemokine mRNAs in chronic hepatitis C
by: Franz Ludwig Dumoulin, et al.
Published: (2004-01-01)

Application of loop-mediated isothermal amplification of DNA for diagnosis of prostate cancer micrometastases in the lymph nodes
by: M. Yu. Shkurnikov, et al.
Published: (2017-06-01)

Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
by: McNally CJ, et al.
Published: (2020-07-01)

Development of a method for evaluating the mRNA transcription activity of influenza virus RNA-dependent RNA polymerase through real-time reverse transcription polymerase chain reaction
by: Yuka Horio, et al.
Published: (2021-08-01)

Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific RNA-Based Aptamer Labelled with Ferrocene
by: Alexei Nabok, et al.
Published: (2021-03-01)

Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
by: S. Fontenete, et al.
Published: (2011-12-01)

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?
by: Alessandro Tafuri, et al.
Published: (2021-06-01)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
by: Nilay M. Gandhi, et al.
Published: (2014-11-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
by: Junli Deng, et al.
Published: (2017-03-01)

Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
by: Lucile Broncy, et al.
Published: (2019-07-01)

A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer
by: Carmelo Agostino Di Franco, et al.
Published: (2017-03-01)